GRAL Company Profile and Key Details

GRAIL, Inc. has 36.05 million shares outstanding. The public float is 24.18 million shares, elevated short interest at 15.40% of float. This equals 4.81 million shares. The short ratio is 4.38 days. Institutional investors hold 85.03% of the float. Insiders own 13.81%. ILLUMINA, INC. holds 3.50 million shares, DING CHUN R has 3.31 million shares and RAGUSA ROBERT P has 688.03 thousand shares. Over the past six months, insider transactions show net selling. They sold 1.21 million shares across 15 transactions.

GRAIL, Inc. (NASDAQ:GRAL) closed at $90.98 USD, losing -$3.37 (-3.57%) from the previous close of $94.35. The stock is currently mid-range between its 52-week high and low $16.56 and $115.76. With a market capitalization of about $3.18 billion, GRAIL, Inc. is classified as a mid-cap and shows higher-than-market volatility (beta ~4.26). Key stats such as the average daily volume over the past year has been around 1.14 million shares, volume is running light vs its 52-week average. Headquartered in Menlo Park, CA, GRAIL, Inc. operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Robert Ragusa, the company employs approximately 1,000 people and listed since June 12, 2024. GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection.

GRAIL, Inc. generated EPS of -$11.61 over the past year. Five-year average earnings growth is -89.93%. Wall Street analysts project EPS growth of 44.25% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 4 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $110.00 to $20.00. The high target offers 16.59% upside. The low target suggests -78.8% downside. The mean target is $82.50. This offers -12.56% upside. GRAIL, Inc. earnings surprise history is a mixed track record. The quarter that ended November 12, 2025, missed forecasts by -27.56%. The prior quarter beat by 1.27%. Over the last six quarters, Apple has recorded several small beats. These include -38.72% in November 12, 2024.

GRAL has shown sold momentum, gaining 3.89% over the past week and 112.12% over the past quarter, though year-to-date performance is up 428.57%. Short-term trend indicators are bearishly aligned (SMA20 -3.62%, SMA50 5.56%, SMA200 85.87%). The stock’s 14-day RSI is 52.69 (neutral), while the ATR of 6.76 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -18.5% below its high and over 470.09% above its low. Average 10-day trading volume of 1.08 million shares is in line with the 3-month average of 1.14 million, indicating normal recent market interest.

GRAIL, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$76.60. This means the shares are trading below this model’s fair value.

GRAIL, Inc. (NASDAQ:GRAL) shares are up 428.57% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows GRAIL, Inc. trading at a premium to the broader market with a P/E of -8.37. Analyst sentiment is cautious, with the majority of ratings in Equal-Weight territory and a mean price target of $73.00, suggesting -22.63% downside. Our AI forecast model points to short-term strength (4.08% over two weeks), a medium-term rise (51.26% over three months), and a longer-term gain (44.06% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that GRAIL, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 4.08%, with price expected at $98.20 by January 05, 2026, within a range of $87.92 to $108.24 3-Month Outlook: Projected rise of 51.26%, reaching $142.71 by March 20, 2026, with a range of $141.43 to $143.99. 1-Year Outlook: Projected gain of 44.06%, with price at $135.92 by December 22, 2026, within a range of $131.73 to $139.99.

GRAIL, Inc. trades at a P/E ratio of -8.37, slightly below the S&P 500 average, with a price-to-sales ratio of 23.21 and a price-to-book ratio of 1.52 suggesting the stock is closer to book value. The P/FCF stands at -8.85, also below market averages.